Cite
HARVARD Citation
Gibbs, J. et al. (2015). Impact of target-mediated elimination on evolocumab dose and regimen. Atherosclerosis. 241 (1), pp. e197-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gibbs, J. et al. (2015). Impact of target-mediated elimination on evolocumab dose and regimen. Atherosclerosis. 241 (1), pp. e197-. [Online].